About New York Neurology Associates
Clinical Trials at New York Neurology Associates
During the past decade, New York Neurology Associates conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "New York Neurology Associates" #1 sponsor was "Pfizer" with 3 trials, followed by "Emalex Biosciences Inc." with 2 trials
sponsored, "NYU Langone Health" with 2 trials sponsored, "AEON Biopharma, Inc." with 1 trials sponsored and "BioVie Inc."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "New York Neurology Associates"
#1 collaborator was "Boston Children's Hospital" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at New York Neurology Associates
According to Clinical.Site data, the most researched conditions in "New York Neurology Associates" are
"Epilepsy" (2 trials), "Migraine" (2 trials), "Parkinson Disease" (2 trials), "Acute Treatment of Migraine" (1 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "New York Neurology Associates" in a lesser frequency.
Clinical Trials Intervention Types at New York Neurology Associates
Most popular intervention types in "New York Neurology Associates" are "Drug" (9 trials) and "Device" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ecopipam" (2 trials), "ABP-450" (1 trials), "BHV-3500 (zavegepant)" (1 trials) and "CVN424 High Dose" (1 trials). Other intervention names were less common.
Clinical Trials Genders at New York Neurology Associates
The vast majority of trials in "New York Neurology Associates" are
12 trials for "All" genders.
Clinical Trials Status at New York Neurology Associates
Currently, there are NaN active trials in "New York Neurology Associates".
undefined are not yet recruiting,
5 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in New York Neurology Associates,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in New York Neurology Associates, 2 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".